Skip to main content
. 2021 Jun 3;9:25. doi: 10.1186/s40170-021-00261-w

Table 5.

Risk of head and neck cancer according to CRP and the joint effect of MS and CRP

No. of cases/person-years Model 1 Model 2 Model 3
HR (95% CI) P HR (95% CI) P HR (95% CI) P
CRP
 < 1.00 mg/dL 223/1155432 Reference Reference Reference
 ≥ 1.00 mg/dL 531/1750092 1.39[1.18, 1.62] <0.001 1.44[1.23, 1.68] <0.001 1.21[1.03, 1.42] 0.021
Joint effect of MS and CRP p-interaction=0.501
 No MS/CRP < 1.00 mg/dL 181/1027524 Reference Reference Reference
 No MS/CRP ≥ 1.00 mg/dL 327/1153876 1.42[1.19, 1.72] <0.001 1.45[1.21, 1.73] <0.001 1.22[1.02, 1.47] 0.033
 MS/CRP < 1.00 mg/dL 42/127908 1.50[1.07, 2.10] 0.018 1.30[0.93, 1.82] 0.126 1.20[0.85, 1.68] 0.298
 MS/CRP ≥ 1.00 mg/dL 204/596216 1.58[1.29, 1.93] <0.001 1.61[1.31, 1.96] <0.001 1.29[1.05, 1.58] 0.017

Model 1: unadjusted

Model 2: age and gender-stratified model

Model 3: additionally adjusted for education, ethnic, index of multiple deprivation, alcohol consumption, smoking status, physical activity, fruit and vegetable intake, and NASIDS use